These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 12584740

  • 1. Treatment of colon and breast carcinoma cells with 5-fluorouracil enhances expression of carcinoembryonic antigen and susceptibility to HLA-A(*)02.01 restricted, CEA-peptide-specific cytotoxic T cells in vitro.
    Correale P, Aquino A, Giuliani A, Pellegrini M, Micheli L, Cusi MG, Nencini C, Petrioli R, Prete SP, De Vecchis L, Turriziani M, Giorgi G, Bonmassar E, Francini G.
    Int J Cancer; 2003 Apr 20; 104(4):437-45. PubMed ID: 12584740
    [Abstract] [Full Text] [Related]

  • 2. 5-fluorouracil-based chemotherapy enhances the antitumor activity of a thymidylate synthase-directed polyepitopic peptide vaccine.
    Correale P, Del Vecchio MT, Di Genova G, Savellini GG, La Placa M, Terrosi C, Vestri M, Urso R, Lemonnier F, Aquino A, Bonmassar E, Giorgi G, Francini G, Cusi MG.
    J Natl Cancer Inst; 2005 Oct 05; 97(19):1437-45. PubMed ID: 16204693
    [Abstract] [Full Text] [Related]

  • 3. In vitro generation of cytotoxic T lymphocytes against HLA-A2.1-restricted peptides derived from human thymidylate synthase.
    Correale P, Sabatino M, Cusi MG, Micheli L, Nencini C, Pozzessere D, Petrioli R, Aquino A, De Vecchis L, Turriziani M, Prete SP, Sanguedolce R, Rausa L, Giorgi G, Francini G.
    J Chemother; 2001 Oct 05; 13(5):519-26. PubMed ID: 11760216
    [Abstract] [Full Text] [Related]

  • 4. More efficient induction of HLA-A*0201-restricted and carcinoembryonic antigen (CEA)-specific CTL response by immunization with exosomes prepared from heat-stressed CEA-positive tumor cells.
    Dai S, Wan T, Wang B, Zhou X, Xiu F, Chen T, Wu Y, Cao X.
    Clin Cancer Res; 2005 Oct 15; 11(20):7554-63. PubMed ID: 16243831
    [Abstract] [Full Text] [Related]

  • 5. Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro.
    Correale P, Cusi MG, Del Vecchio MT, Aquino A, Prete SP, Tsang KY, Micheli L, Nencini C, La Placa M, Montagnani F, Terrosi C, Caraglia M, Formica V, Giorgi G, Bonmassar E, Francini G.
    J Immunol; 2005 Jul 15; 175(2):820-8. PubMed ID: 16002679
    [Abstract] [Full Text] [Related]

  • 6. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
    Saha A, Chatterjee SK, Foon KA, Celis E, Bhattacharya-Chatterjee M.
    Cancer Res; 2007 Mar 15; 67(6):2881-92. PubMed ID: 17363612
    [Abstract] [Full Text] [Related]

  • 7. MC32 tumor cells acquire Ag-specific CTL resistance through the loss of CEA in a colon cancer model.
    Lee SY, Sin JI.
    Hum Vaccin Immunother; 2015 Mar 15; 11(8):2012-20. PubMed ID: 25902414
    [Abstract] [Full Text] [Related]

  • 8. Identification of an enhancer agonist cytotoxic T lymphocyte peptide from human carcinoembryonic antigen.
    Zaremba S, Barzaga E, Zhu M, Soares N, Tsang KY, Schlom J.
    Cancer Res; 1997 Oct 15; 57(20):4570-7. PubMed ID: 9377571
    [Abstract] [Full Text] [Related]

  • 9. Differential role of Fas/Fas ligand interactions in cytolysis of primary and metastatic colon carcinoma cell lines by human antigen-specific CD8+ CTL.
    Bergmann-Leitner ES, Abrams SI.
    J Immunol; 2000 May 01; 164(9):4941-54. PubMed ID: 10779805
    [Abstract] [Full Text] [Related]

  • 10. Novel system for generating cytotoxic effector lymphocytes using carcinoembryonic antigen (CEA) peptide and cultured dendritic cells.
    Ohta K, Yamaguchi Y, Shimizu K, Miyahara E, Toge T.
    Anticancer Res; 2002 May 01; 22(5):2597-606. PubMed ID: 12529970
    [Abstract] [Full Text] [Related]

  • 11. In vitro induction of HLA-A2402-restricted and carcinoembryonic-antigen-specific cytotoxic T lymphocytes on fixed autologous peripheral blood cells.
    Kim C, Matsumura M, Saijo K, Ohno T.
    Cancer Immunol Immunother; 1998 Oct 01; 47(2):90-6. PubMed ID: 9769117
    [Abstract] [Full Text] [Related]

  • 12. Chemotherapeutic drugs may be used to enhance the killing efficacy of human tumor antigen peptide-specific CTLs.
    Correale P, Del Vecchio MT, La Placa M, Montagnani F, Di Genova G, Savellini GG, Terrosi C, Mannucci S, Giorgi G, Francini G, Cusi MG.
    J Immunother; 2008 Oct 01; 31(2):132-47. PubMed ID: 18481383
    [Abstract] [Full Text] [Related]

  • 13. Phenotypic stability of a cytotoxic T-cell line directed against an immunodominant epitope of human carcinoembryonic antigen.
    Tsang KY, Zhu M, Nieroda CA, Correale P, Zaremba S, Hamilton JM, Cole D, Lam C, Schlom J.
    Clin Cancer Res; 1997 Dec 01; 3(12 Pt 1):2439-49. PubMed ID: 9815645
    [Abstract] [Full Text] [Related]

  • 14. A loss of antitumor therapeutic activity of CEA DNA vaccines is associated with the lack of tumor cells' antigen presentation to Ag-specific CTLs in a colon cancer model.
    Ahn E, Kim H, Han KT, Sin JI.
    Cancer Lett; 2015 Jan 28; 356(2 Pt B):676-85. PubMed ID: 25449428
    [Abstract] [Full Text] [Related]

  • 15. Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes.
    Brossart P, Stuhler G, Flad T, Stevanovic S, Rammensee HG, Kanz L, Brugger W.
    Cancer Res; 1998 Feb 15; 58(4):732-6. PubMed ID: 9485028
    [Abstract] [Full Text] [Related]

  • 16. Identification of an antigenic epitope for helper T lymphocytes from carcinoembryonic antigen.
    Kobayashi H, Omiya R, Ruiz M, Huarte E, Sarobe P, Lasarte JJ, Herraiz M, Sangro B, Prieto J, Borras-Cuesta F, Celis E.
    Clin Cancer Res; 2002 Oct 15; 8(10):3219-25. PubMed ID: 12374692
    [Abstract] [Full Text] [Related]

  • 17. Host-oriented peptide evaluation using whole blood assay for generating antigen-specific cytotoxic T lymphocytes.
    Kawabuchi Y, Yamaguchi Y, Ohshita A, Minami K, Toge T.
    Anticancer Res; 2004 Oct 15; 24(2C):1193-200. PubMed ID: 15154646
    [Abstract] [Full Text] [Related]

  • 18. Treatment of human colon carcinoma cell lines with anti-neoplastic agents enhances their lytic sensitivity to antigen-specific CD8+ cytotoxic T lymphocytes.
    Bergmann-Leitner ES, Abrams SI.
    Cancer Immunol Immunother; 2001 Nov 15; 50(9):445-55. PubMed ID: 11761438
    [Abstract] [Full Text] [Related]

  • 19. Induction of specific CTL by MAGE-3/CEA peptide-pulsed dendritic cells from HLA-A2/A24(+) gastrointestinal cancer patients.
    Hao X, Shao Y, Ren X, Liu H, Xu Q, Li H, Zhang P, An X, Ren B.
    J Cancer Res Clin Oncol; 2002 Sep 15; 128(9):507-15. PubMed ID: 12242516
    [Abstract] [Full Text] [Related]

  • 20. HLA-A*0201-restricted CEA-derived peptide CAP1 is not a suitable target for T-cell-based immunotherapy.
    Fauquembergue E, Toutirais O, Tougeron D, Drouet A, Le Gallo M, Desille M, Cabillic F, de La Pintière CT, Iero M, Rivoltini L, Baert-Desurmont S, Leprince J, Vaudry H, Sesboué R, Frébourg T, Latouche JB, Catros V.
    J Immunother; 2010 May 15; 33(4):402-13. PubMed ID: 20386466
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.